Effects of RSV infection on pulmonary surfactant protein SP-A in cultured human type II cells: Contrasting consequences on SP-A mRNA and protein

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 6 33-6, 2005, Pages

  Alcorn, Joseph L ^a   Stark, James M ^a   Chiappetta, Constance L ^a   Jenkins, Gaye ^a   Colasurdo, Giuseppe N ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Alveolar type II cell; Respiratory syncytial virus; Surfactant protein A

Indexed keywords

MESSENGER RNA; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; FETUS; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; LAMELLAR BODY; LOWER RESPIRATORY TRACT INFECTION; LUNG ALVEOLUS CELL TYPE 2; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERINFECTION; WESTERN BLOTTING;

CELLS, CULTURED; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION, VIRAL; HOMEOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 27944474012     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00436.2004     Document Type: Article

References (60)

1. Abramson JS and Wheeler JG. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr Infect Dis J 13: 643-652, 1994.
2. Alcorn JL, Smith ME, Smith JF, Margraf LR, and Mendelson CR. Primary cell culture of human type II pneumonocytes: maintenance of a differentiated phenotype and transfection with recombinant adenoviruses. Am J Respir Cell Mol Biol 17: 672-682, 1997.
3. Al-Barraji AM, Cutlip RC, and Lehmkuhl HD. Experimental infection of lambs with bovine respiratory syncytial virus and Pasteurella haemolytica: immunofluorescent and electron microscopic studies. Am J Vet Res 43: 230-235, 1982.
4. Al-Darraji AM, Cutlip RC, Lehmkuhl HD, and Graham DL. Experimental infection of lambs with bovine respiratory syncytial virus and Pasteurella haemolytica: pathologic studies. Am J Vet Res 43: 224-229, 1982.
5. Al-Darraji AM, Cutlip RC, Lehmkuhl HD, Graham DL, Kluge JP, and Frank GH. Experimental infection of lambs with bovine respiratory syncytial virus and Pasteurella haemolytica: clinical and microbiologic studies. Am J Vet Res 43: 236-240, 1982.
6. Andrade MA, Hoberman A, Glustein J, Paradise JL, and Wald ER. Acute otitis media in children with bronchiolitis. Pediatrics 101: 617-619, 1998.
7. Blount RE Jr, Morris JA, and Savage RE. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med 92: 544-549, 1956.
8. Brogden KA, Lehmkuhl HD, and Cutlip RC. Pasteurella haemolytica complicated respiratory infections in sheep and goats. Vet Res 29: 233-254, 1998.
9. Carfrae DC, Bell EJ, and Grist NR. Fatal haemorrhagic pneumonia in an adult due to respiratory syncytial virus and Staphylococcus aureus. J Infect 4: 79-80, 1982.
10. Clements JA and King RJ. The Biochemical Basis of Pulmonary Function, edited by Crystal RG. New York: Dekker, 1976, p. 363-387.
11. Crouch E and Wright JR. Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol 63: 521-554, 2001.
12. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 19: 177-201, 1998.
13. Crouch EC. Modulation of host-bacterial interactions by collectins. Am J Respir Cell Mol Biol 21: 558-561, 1999.
14. Denny FW and Clyde WA Jr. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr 108: 635-646, 1986.
15. Foy HM, Cooney MK, Maletzky AJ, and Grayston JT. Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period. Am J Epidemiol 97: 80-92, 1973.
16. Gibson UE, Heid CA, and Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 6: 995-1001, 1996.
17. Gonzales LW, Angampalli S, Guttentag SH, Beers MF, Feinstein SI, Matlapudi A, and Ballard PL. Maintenance of differentiated function of the surfactant system in human fetal lung type II epithelial cells cultured on plastic. Pediatr Pathol Mol Med 20: 387-412, 2001.
18. Gonzales LW, Guttentag SH, Wade KC, Postle AD, and Ballard PL. Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cAMP. Am J Physiol Lung Cell Mol Physiol 283: L940-L951, 2002.
19. Graham BS, Perkins MD, Wright PF, and Karzon DT. Primary respiratory syncytial virus infection in mice. J Med Virol 26: 153-162, 1988.
20. Griese M. Respiratory syncytial virus and pulmonary surfactant. Viral Immunol 15: 357-363, 2002.
21. Haagsman HP and Diemel RV. Surfactant-associated proteins: functions and structural variation. Comp Biochem Physiol A Mol Integr Physiol 129: 91-108, 2001.
22. Hawgood S and Shiffer K. Structures and properties of the surfactant-associated proteins. Annu Rev Physiol 53: 375-394, 1991.
23. Heid CA, Stevens J, Livak KJ, and Williams PM. Real time quantitative PCR. Genome Res 6: 986-994, 1996.
24. Islam KN and Mendelson CR. Potential role of nuclear factor κB and reactive oxygen species in cAMP and cytokine regulation of surfactant protein-A gene expression in lung type II cells. Mol Endocrinol 16: 1428-1440, 2002.
25. Kao YJ, Piedra PA, Larsen GL, and Colasurdo GN. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am J Respir Crit Care Med 163: 532-539, 2001.
26. Kerr MH and Paton JY. Surfactant protein levels in severe respiratory syncytial virus infection. Am J Respir Crit Care Med 159: 1115-1118, 1999.
27. Kong X, San Juan H, Kumar M, Behera AK, Mohapatra A, Hellermann GR, Mane S, Lockey RF, and Mohapatra SS. Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Biochem Biophys Res Commun 306: 616-622, 2003.
28. Korfhagen TR. Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis. Am J Respir Cell Mol Biol 25: 668-672, 2001.
29. Korfhagen TR, LeVine AM, and Whitsett JA. Surfactant protein A (SP-A) gene targeted mice. Biochim Biophys Acta 1408: 296-302, 1998.
30. Korppi M, Koskela M, Jalonen E, and Leinonen M. Serologically indicated pneumococcal respiratory infection in children. Scand J Infect Dis 24: 437-443, 1992.
31. Korppi M, Leinonen M, Koskela M, Makela PH, and Launiala K. Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr Infect Dis J 8: 687-692, 1989.
32. LeVine AM, Koeningsknecht V, and Stark JM. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods 94: 173-186, 2001.
33. LeVine AM and Whitsett JA. Pulmonary collectins and innate host defense of the lung. Microbes Infect 3: 161-166, 2001.
34. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, and Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 165: 3934-3940, 2000.
35. Lofgren J, Ramet M, Renko M, Marttila R, and Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 185: 283-289, 2002.
36. Magdaleno SM, Wang G, Jackson KJ, Ray MK, Welty S, Costa RH, and DeMayo FJ. Interferon-γ regulation of Clara cell gene expression: in vivo and in vitro. Am J Physiol Lung Cell Mol Physiol 272: L1142-L1151, 1997.
37. Mason RJ, Walker SR, Shields BA, Henson JE, and Williams MC. Identification of rat alveolar type II epithelial cells with a tannic acid and polychrome stain. Am Rev Respir Dis 131: 786-788, 1985.
38. McCullers JA and Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 186: 341-350, 2002.
39. Mendelson CR. Role of transcription factors in fetal lung development and surfactant protein gene expression. Annu Rev Physiol 62: 875-915, 2000.
40. Mufson MA, Krause HE, Mocega HE, and Dawson FW. Viruses, Mycoplasma pneumoniae and bacteria associated with lower respiratory tract disease among infants. Am J Epidemiol 91: 192-202, 1970.
41. Mufson MA, Levine HD, Wasil RE, Mocega-Gonzalez HE, and Krause HE. Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am J Epidemiol 98: 88-95, 1973.
42. Nohynek H, Eskola J, Laine E, Halonen P, Ruutu P, Saikku P, Kleemola M, and Leinonen M. The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child 145: 618-622, 1991.
43. Odom MJ, Snyder JM, and Mendelson CR. Adenosine 3′,5′- monophosphate analogs and β-adrenergic agonists induce the synthesis of the major surfactant apoprotein in human fetal lung in vitro. Endocrinology 121: 1155-1163, 1987.
44. Okazaki T, Johnston JM, and Snyder JM. Morphogenesis of the lamellar body in fetal lung tissue in vitro. Biochim Biophys Acta 712: 283-291, 1982.
45. Parrott RH, Kim HW, Arrobio JO, Hodes DS, Murphy BR, Brandt CD, Camargo E, and Chanock RM. Epidemiology of respiratory syncytial virus infection in Washington, DC. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 98: 289-300, 1973.
46. Patel J, Faden H, Sharma S, and Ogra PL. Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. Int J Pediatr Otorhinolaryngol 23: 15-23, 1992.
47. Pryhuber GS, Khalak R, and Zhao Q. Regulation of surfactant proteins A and B by TNF-α and phorbol ester independent of NF-κB. Am J Physiol Lung Cell Mol Physiol 274: L289-L295, 1998.
48. Ramaswamy M, Shi L, Monick MM, Hunninghake GW, and Look DC. Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 30: 893-900, 2004.
49. Rooney SA. Regulation of surfactant secretion. Comp Biochem Physiol A Mol Integr Physiol 129: 233-243, 2001.
50. Shepherd VL. Distinct roles for lung collectins in pulmonary host defense. Am J Respir Cell Mol Biol 26: 257-260, 2002.
51. Stratton CJ. Morphology of surfactant producing cells and the alveolar lining. In: Pulmonary Surfactant, edited by Robertson B, Golde LMGV, and Batenburg JJ. Amsterdam: Elsevier Science, 1984, p. 67-118.
52. Stuart JM, Cartwright K, and Andrews NJ. Respiratory syncytial virus infection and meningococcal disease. Epidemiol Infect 117: 107-111, 1996.
53. Takala AK, Meurman O, Kleemola M, Kela E, Ronnberg PR, Eskola J, and Makela PH. Preceding respiratory infection predisposing for primary and secondary invasive Haemophilus influenzae type b disease. Pediatr Infect Dis J 12: 189-195, 1993.
54. Tian B, Zhang Y, Luxon BA, Garofalo RP, Casola A, Sinha M, and Brasier AR. Identification of NF-κB-dependent gene networks in respiratory syncytial virus-infected cells. J Virol 76: 6800-6814, 2002.
55. Tripp RA. Pathogenesis of respiratory syncytial virus infection. Viral Immunol 17: 165-181, 2004.
56. Van Schaik SM, Enhorning G, Vargas I, and Welliver RC. Respiratory syncytial virus affects pulmonary function in BALB/c mice. J Infect Dis 177: 269-276, 1998.
57. Van Schaik SM, Vargas I, Welliver RC, and Enhorning G. Surfactant dysfunction develops in BALB/c mice infected with respiratory syncytial virus. Pediatr Res 42: 169-173, 1997.
58. Wilmott RW, Khurana-Hershey G, and Stark JM. Current concepts on pulmonary host defense mechanisms in children. Curr Opin Pediatr 12: 187-193, 2000.
59. Xu N, Loflin P, Chen CY, and Shyu AB. A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy. Nucleic Acids Res 26: 558-565, 1998.
60. Zhang L, Ikegami M, Dey CR, Korfhagen TR, and Whitsett JA. Reversibility of pulmonary abnormalities by conditional replacement of surfactant protein D (SP-D) in vivo. J Biol Chem 277: 38709-38713, 2002.